Impact of metabolic syndrome on the outcomes of superficial femoral artery interventions

Journal of Vascular Surgery

Volumn 55, Issue 4, 2012, Pages

  Smolock, Christopher J ^a   Anaya Ayala, Javier E ^a   Bismuth, Jean ^a   Naoum, Joseph J ^a   El Sayed, Hosam F ^a   Peden, Eric K ^a   Lumsden, Alan B ^a   Davies, Mark G ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLAUDICATION; CLINICAL EFFECTIVENESS; ENDOVASCULAR SURGERY; FEMALE; HEMODYNAMICS; HUMAN; LEG AMPUTATION; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOBILIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY; TREATMENT FAILURE;

EID: 84859164070     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.10.109     Document Type: Article

References (41)

1. C.A. Maggio, F.X. Pi-Sunyer Obesity and type 2 diabetes Metab Clin North Am 32 2003 805 822
2. M.G. Davies, D.L. Waldman, T.A. Pearson Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease J Am Coll Surg 201 2005 275 296
3. L.K. Lee, K.C. Kent Infrainguinal occlusive disease: endovascular intervention is the first line therapy Adv Surg 42 2008 193 204
4. A.B. Lumsden, T.S. Das Endovascular management of infrainguinal disease J Endovasc Ther 13 Suppl 2 2006 II1 II2
5. A.B. Lumsden, M.G. Davies, E.K. Peden Medical and endovascular management of critical limb ischemia J Endovasc Ther 16 Suppl II 2009 II-31 II-62
6. B.G. DeRubertis, A. Vouyouka, S.J. Rhee, J. Califano, J. Karwowski, N. Angle Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men J Vasc Surg 38 2008 150 158
7. A.M. Bakken, E. Palchik, J.P. Hart, J.M. Rhodes, W.E. Saad, M.G. Davies Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions J Vasc Surg 46 2007 946 958
8. A.M. Bakken, C.D. Protack, W.E. Saad, J.P. Hart, J.M. Rhodes, D.L. Waldman Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions Ann Vasc Surg 23 2009 560 568
9. M.G. Davies, W.E. Saad, E.K. Peden, I.T. Mohiuddin, J.J. Naoum, A.B. Lumsden Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss J Vasc Surg 48 2008 619 626
10. M.G. Davies, W.E. Saad, E.K. Peden, I.T. Mohiuddin, J.J. Naoum, A.B. Lumsden Percutaneous superficial femoral artery interventions for claudicationdoes runoff matter? Ann Vasc Surg 22 2008 790 798
11. C.D. Protack, A.M. Bakken, J. Xu, W.A. Saad, A.B. Lumsden, M.G. Davies Metabolic syndrome: a predictor of adverse outcomes after carotid revascularization J Vasc Surg 49 2009 1172 1180
12. M.G. Davies, W.E. Saad, J. Bismuth, J.J. Naoum, E.K. Peden, A.B. Lumsden Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting J Vasc Surg 51 2010 926 932
13. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438
14. TASC II Working Group TASC-II: Inter-Society Consensus for the management of peripheral vascular arterial disease J Vasc Surg 45 Suppl S 2007 S1 S67
15. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
16. M.S. Conte, P.J. Geraghty, A.W. Bradbury, N.D. Hevelone, S.R. Lipsitz, G.L. Moneta Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473
17. G. Brevetti, E. Laurenzano, G. Giugliano, S. Lanero, L. Brevetti, R. Luciano Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease Nutr Metab Cardiovasc Dis 20 2010 676 682
18. J.B. Meigs, P.W. Wilson, D.M. Nathan, R.B. D'Agostino Sr, K. Williams, S.M. Haffner Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies Diabetes 52 2003 2160 2167
19. Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436
20. P. Ilanne-Parikka, J.G. Eriksson, J. Lindstrm, H. Hmlinen, S. Keinnen-Kiukaanniemi, M. Laakso Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the diabetes prevention study cohort Diabetes Care 27 2004 2135 2140
21. C.J. Girman, T. Rhodes, M. Mercuri, K. Pyrl, J. Kjekshus, T.R. Pedersen The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Am J Cardiol 93 2004 136 141
22. G. Brevetti, V. Schiano, G. Sirico, G. Giugliano, E. Laurenzano, M. Chiariello Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity J Vasc Surg 44 2006 101 107
23. A. Natali, G. Pucci, B. Boldrini, G. Schillaci Metabolic syndrome: at the crossroads of cardiorenal risk J Nephrol 22 2009 29 38
24. Z.T. Bloomgarden Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome Diabetes Care 27 2004 824 830
25. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
26. M. Maksimovic, H. Vlajinac, D. Radak, J. Marinkovic, J. Jorga Relationship between peripheral arterial disease and metabolic syndrome Angiology 60 2009 546 553
27. E.J. Ryer, S.M. Trocciola, B. DeRubertis, R. Lam, R.L. Hynecek, J. Karwowski Analysis of outcomes following failed endovascular treatment of chronic limb ischemia Ann Vasc Surg 20 2006 440 446
28. S.M. Surowiec, M.G. Davies, S.W. Eberly, J.M. Rhodes, K.A. Illig, C.K. Shortell Percutaneous angioplasty and stenting of the superficial femoral artery J Vasc Surg 41 2005 269 278
29. B.G. DeRubertis, M. Pierce, R.A. Chaer, S.J. Rhee, R. Benjeloun, E.J. Ryer Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention J Vasc Surg 46 2007 709 716
30. W.P. Robinson 3rd, L.L. Nguyen, R. Bafford, M. Belkin Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes J Vasc Surg 53 2011 651 657
31. M.G. Davies, J. Bismuth, W.E. Saad, J.J. Naoum, E.K. Peden, A.B. Lumsden Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease J Vasc Surg 52 2010 331 to 9.e1-2
32. R. Hoffmann, E. Stellbrink, J. Schrder, A. Grawe, G. Vogel, R. Blindt Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents Am J Cardiol 100 2007 1347 1352
33. P. Canibus, E. Faloia, T. Piva, A. Muai, M. Serenelli, G.P. Perna Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation Metabolism 57 2008 593 597
34. D. Vykoukal, M.G. Davies Metabolic syndrome and vascular outcomes M. Eskandari, M. Morasch, W.H. Pearce, J.S.T. Yao, Vascular surgery 2011 Peoples Medical Publishing House-USA (PMPH-USA) Shelton, CT 243 254
35. J.S. Rana, P.S. Monraats, A.H. Zwinderman, M.P. de Maat, J.J. Kastelein, P.A. Doevendans Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention Diabetes Care 28 2005 873 877
36. J.S. Kim, H.C. Lee, B.K. Choi, H.W. Lee, J.S. Park, Y.H. Lee Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation Diabetes Res Clin Pract 88 2010 e38 e41
37. P.P. Goodney, A.W. Beck, J. Nagle, H.G. Welch, R.M. Zwolak National trends in lower extremity bypass surgery, endovascular interventions, and major amputations J Vasc Surg 50 2009 54 60
38. G. Sarno, S. Garg, Y. Onuma, P. Buszman, A. Linke, T. Ischinger The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with biolimus- and sirolimus-eluting stents (from the LEADERS Trial) Am J Cardiol 105 2010 475 479
39. T. Kasai, K. Miyauchi, T. Kurata, H. Ohta, S. Okazaki, T. Miyazaki Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention Circ J 70 2006 1531 1537
40. T. Kasai, K. Miyauchi, T. Kurata, S. Okazaki, K. Kajimoto, N. Kubota Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention Hypertens Res 31 2008 235 241
41. T.H. Lee, E.R. Marcantonio, C.M. Mangione, E.J. Thomas, C.A. Polanczyk, E.F. Cook Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery Circ J 100 1999 1043 1049